Sorry, it's all there in RDGL updates and financials for anyone who cares to read. IsoPet is hopelessly unprofitable. Yet it remains MK's highest priority. That's gross incompetence on display.
Per recent updates, RDGL is still unable to manufacture Radiogel to FDA standards. MK is messing with basic issues that competent management would have put to bed years ago.
Facts are facts.
And what does pps mean at continuing anemic volume? Didn't even hit already very low average volume yesterday. Gotta keep it real.
News 
Market Data 
Discover 
AI
